[Increase of renal failure after treatment of malignant hypertension by captopril (author's transl)].
In a 25-year-old woman with malignant hypertension based on primary nephrosclerosis, captopril, an oral inhibitor of angiotension I-converting enzyme, lowered blood pressure effectively, which had been resistant previously to other oral antihypertensive drugs. Concomitantly with the decrease of the high blood pressure, an increase of creatinine from 2.1 mg% to 8.5 mg% occurred. There is evidence that this increase of renal failure is a consequence of blood pressure reduction and is not caused by a toxic effect of captopril.
D000328:Adult; D002216:Captopril / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D011392:Proline / Q000031:analogs & derivatives*
D011392:Proline; D002216:Captopril; D003404:Creatinine
Zunehmende Niereninsuffizienz nach Blutdrucksenkung mit Captopril bei maligner Hypertonie.